EcoR1 Capital, LLC's Form 4 filing
Zymeworks Inc. (ZYME) · filed Jan 15, 2025
- Accession no.
- 0000935836-25-000067
- Filed
- Jan 15, 2025
- Trade date
- Jan 13-15, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market purchases total $2.28M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| EcoR1 Capital, LLCCIK 0001587114 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 13, 2025 | Common Stock | PPurchaseAcquired | +74,125 | $13.39 | +$992,533.75 | 15,485,203 | Indirect | |
| Jan 14, 2025 | Common Stock | PPurchaseAcquired | +54,500 | $13.56 | +$739,020 | 15,539,703 | Indirect | |
| Jan 15, 2025 | Common Stock | PPurchaseAcquired | +39,029 | $14.01 | +$546,796.29 | 15,578,732 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Scott Platshon, an employee of EcoR1, serves as a director of the Issuer and was nominated for the board by EcoR1 and the Funds.